Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion type Assertion NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_head.
- NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_provenance.
- NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion evidence source_evidence_literature NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_provenance.
- NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion SIO_000772 14583450 NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_provenance.
- NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion wasDerivedFrom befree-20150227 NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_provenance.
- NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion wasGeneratedBy ECO_0000203 NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_provenance.